W. D. Hardy
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 15
- HIV Research and Treatment 15
- Immunology 21
- T-cell and Retrovirus Studies 11
- Co-authors
- Max EssexS. M. CotterA. H. SliskiR. M. JakowskiD. P. FrancisU. Fritz BredeekChloe OrkinMark Bloch
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Nature (3 papers)Clinical Infectious Diseases (2 papers)The Journal of Immunology (2 papers)HIV Medicine (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
W. D. Hardy
49 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Virology 600
- Infectious Diseases 711
- Emergency Medicine 196
- Epidemiology 669
- Immunology 379
Countries citing papers authored by W. D. Hardy
This map shows the geographic impact of W. D. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. D. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. D. Hardy more than expected).
Fields of papers citing papers by W. D. Hardy
This network shows the impact of papers produced by W. D. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. D. Hardy. The network helps show where W. D. Hardy may publish in the future.
Co-authors
The 25 scholars most cited alongside W. D. Hardy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 24 | |
| 2 | Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study Hit paper breakdown → | 2013 | 404 |
| 3 | 2013 | 118 | |
| 4 | 2012 | 61 | |
| 5 | 2011 | 28 | |
| 6 | 2008 | 48 | |
| 7 | 2006 | 13 | |
| 8 | 2002 | 33 | |
| 9 | 1999 | 29 | |
| 10 | 1998 | 72 | |
| 11 | 1997 | 4 | |
| 12 | 1992 | 46 | |
| 13 | 1991 | 9 | |
| 14 | 1991 | 68 | |
| 15 | 1991 | 8 | |
| 16 | Focus on aerosolized pentamidine: an agent for prophylaxis of Pneumocystis carinii pneumonia. | 1990 | 1 |
| 17 | 1989 | 30 | |
| 18 | 1981 | 5 | |
| 19 | Immune response to leukemia virus and tumor-associated antigens in cats. | 1976 | 34 |
| 20 | 1975 | 71 |
About W. D. Hardy
W. D. Hardy is a scholar working on Virology, Immunology, Genetics, Epidemiology and Agronomy and Crop Science, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (27 papers), HIV Research and Treatment (15 papers), T-cell and Retrovirus Studies (11 papers), Hepatitis B Virus Studies (10 papers), Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (7 papers), Animal Disease Management and Epidemiology (6 papers) and Animal Virus Infections Studies (4 papers). The work is most often cited by research in Virology (600 citations), Infectious Diseases (711 citations), Emergency Medicine (196 citations), Epidemiology (669 citations) and Immunology (379 citations). W. D. Hardy has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Max Essex, S. M. Cotter, A. H. Sliski, R. M. Jakowski, D. P. Francis, U. Fritz Bredeek, Chloe Orkin, Mark Bloch, Clare Brennan and Daniel Podzamczer. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Nature, Clinical Infectious Diseases, The Journal of Immunology and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.